MedTrace Logo

Treatment of Intraocular Retinoblastoma

NCT05028270 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2022-06-01

No results posted yet for this study

Summary

This study compares the effects of balloon technology and microcatheter technology on the eye protection rate of neuroblastoma

Conditions

  • Retinoblastoma

Interventions

PROCEDURE

Balloon technology;Microcatheter technology

Describe each group's intervention in sufficient detail, including how and when to give the intervention Suspend or modify the criteria for interventions that have been assigned to the subject (such as changing the dose of the drug due to hazards or subject requirements or improvement/deterioration of the condition, etc.) Strategies to improve the compliance of intervention programs, and other measures to monitor compliance (such as the return of drug tablets, laboratory inspections, etc.) Related care and interventions allowed or prohibited during the trial

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Min Shi · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-20
Primary Completion
2022-10-01
Completion
2023-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05028270 on ClinicalTrials.gov